HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Charles T. Klodell, Jr Edward D. Staples Philip J. Hess Tomas D. Martin Thomas M. Beaver Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klodell, C. T. Articles by Beaver, T. M. Search for Related Content PubMed PubMed Citation Articles by Klodell, C. T., Jr Articles by Beaver, T. M. Related Collections Mechanical Circulatory Assistance

Ann Thorac Surg 2007;83:68-71
© 2007 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Effect of Sildenafil on Pulmonary Artery Pressure, Systemic Pressure, and Nitric Oxide Utilization in Patients With Left Ventricular Assist Devices

^a Department of Surgery, University of Florida College of Medicine, Gainesville, Florida
^b Department of Anesthesiology, University of Florida College of Medicine, Gainesville, Florida
^c Department of Medicine, University of Florida College of Medicine, Gainesville, Florida

Accepted for publication August 22, 2006.

^_* Address correspondence to Dr Klodell, Thoracic and Cardiovascular Surgery, PO Box 100286, 1600 SW Archer Rd, Gainesville, FL 32610 (Email: klodell{at}surgery.ufl.edu).

Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30–Feb 1, 2006.

BACKGROUND: Pulmonary artery hypertension can complicate the early postoperative care of patients with left ventricular assist devices (LVADs). Inhaled nitric oxide (INO) is frequently used to manipulate pulmonary resistance after LVADs have been placed. We evaluated the effect of oral sildenafil therapy on pulmonary artery pressure, systemic pressure, and nitric oxide utilization.

METHODS: After Institutional Review Board approval, the records of 10 consecutive adult patients with LVADs and pulmonary hypertension who received sildenafil were reviewed. Demographics, surgical history, INO use, inotrope requirements, and hemodynamic response to oral sildenafil at multiple intervals were collected. Hemodynamic data were analyzed with a two-way analysis of variance of repeated measures with correction for multiple comparisons.

RESULTS: There were 8 men and 2 women with 6 Heartmate XVE LVADs and 4 Thoratec LVADs (both, Thoratec, Pleasanton, California). When weaning was attempted, 8 patients who received INO demonstrated rebound pulmonary hypertension or increased right heart dysfunction. All patients were on inotropic therapy with dobutamine and milrinone. Sildenafil produced a significant reduction in pulmonary artery systolic pressure within 90 minutes of oral administration (p = 0.042). Significant changes in systolic blood pressure, mean arterial pressure, systemic vascular resistance, and heart rate were not observed. All 8 patients receiving INO were weaned within 12 hours without recurrent pulmonary hypertension. All 10 patients were weaned from inotropic support within 72 hours. No patient suffered right-side heart failure requiring intervention.

CONCLUSIONS: Oral sildenafil represents a useful adjunctive therapy for patients with LVADs. In our series, it provided additional reduction of pulmonary artery pressure, and facilitated weaning from INO and inotropes without deleterious hemodynamic consequences.

This article has been cited by other articles:

				D. Matamis, S. Pampori, A. Papathanasiou, P. Papakonstantinou, M. Tsagourias, E. Galiatsou, V. Koulouras, and G. Nakos Inhaled NO and Sildenafil Combination in Cardiac Surgery Patients With Out-of-Proportion Pulmonary Hypertension: Acute Effects on Postoperative Gas Exchange and Hemodynamics Circ Heart Fail, January 1, 2012; 5(1): 47 - 53. [Abstract] [Full Text] [PDF]

				S. J. Melby, M. R. Moon, B. R. Lindman, M. S. Bailey, L. L. Hill, and R. J. Damiano Jr. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J. Thorac. Cardiovasc. Surg., June 1, 2011; 141(6): 1424 - 1430. [Abstract] [Full Text] [PDF]

				C. R. Ensor, C. A. Paciullo, W. D. Cahoon Jr, and P. E. Nolan Jr Pharmacotherapy for Mechanical Circulatory Support: A Comprehensive Review Ann. Pharmacother., January 1, 2011; 45(1): 60 - 77. [Abstract] [Full Text] [PDF]

				T. Lahm, C. A. McCaslin, T. C. Wozniak, W. Ghumman, Y. Y. Fadl, O. S. Obeidat, K. Schwab, and D. R. Meldrum Medical and Surgical Treatment of Acute Right Ventricular Failure J. Am. Coll. Cardiol., October 26, 2010; 56(18): 1435 - 1446. [Abstract] [Full Text] [PDF]

				A. Loforte, A. Montalto, P. Lilla Della Monica, and F. Musumeci Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure Interact CardioVasc Thorac Surg, June 1, 2010; 10(6): 847 - 850. [Abstract] [Full Text] [PDF]

				R. J. Tedford, A. R. Hemnes, S. D. Russell, I. S. Wittstein, M. Mahmud, A. L. Zaiman, S. C. Mathai, D. R. Thiemann, P. M. Hassoun, R. E. Girgis, et al. PDE5A Inhibitor Treatment of Persistent Pulmonary Hypertension After Mechanical Circulatory Support Circ Heart Fail, November 1, 2008; 1(4): 213 - 219. [Abstract] [Full Text] [PDF]

				T. M. Beaver Invited commentary Ann. Thorac. Surg., July 1, 2007; 84(1): 85 - 86. [Full Text] [PDF]